Document:

Separation Agreement by and between Amedica and Eugene B. Jones

 Exhibit 10.18 
  
 

 
  
 January 5, 2007 
  
 Mr. Eugene B. Jones 
  
 Dear Gene: 
  
 The purpose of this letter agreement (the “Agreement”) is to
confirm the terms regarding your separation of employment from Amedica Corporation, a Delaware corporation (the “Company”). As more fully set forth below, the Company desires to provide you with severance pay in exchange for certain
agreements by you. 
  
 1. Separation of Employment.
You acknowledge that, pursuant to your retirement, your employment with the Company will terminate effective Friday, January 5, 2007 (the “Separation Date”). You acknowledge that from and after the Separation Date, you shall have
no authority and shall not represent yourself as an employee or agent of the Company. This Agreement shall become effective (the “Effective Date”) on the 8th day following your acceptance of it as provided below. 
  
 2. Severance Pay/Options. In exchange for the mutual covenants
set forth in this Agreement, 
  
 (i) the Company is providing you
with a lump sum payment of $95,566, less all applicable federal, state, local and other employment-related deductions; you acknowledge that such payment was advanced to you prior to December 31, 2006 and the execution of this Agreement, but you
have agreed and do agree that should you not accept or rescind your acceptance of this agreement, as you may under the provisions set forth below, you thereafter shall immediately refund such payment to the Company at the conclusion of the time in
which you may accept this Agreement (or on rejection should you reject it prior to such time) or, should you accept and later rescind, contemporaneously with your notice of rescission; 
  
 (ii) all stock options previously granted to you by the Company which are currently in effect (collectively, the
“Existing Stock Options”) shall terminate and be of no further force or effect immediately upon the grant to you by the Company of a nonqualified stock option exercisable for up to 65,000 shares of the Company’s common stock (the
“New Stock Option”). The New Stock Option shall expire not later than June 30, 2014, and shall have an exercise price per share equal to the fair market value of a share of the Company’s common stock on the date of grant. The
grant to you of the New Stock Option is subject to the approval of the Company’s Board of Directors and unless and until the Board acts, the Existing Stock Options shall remain in full force and effect in accordance with their respective terms.

 You acknowledge and agree that the Severance Pay provided in this Agreement are not otherwise due or
owing to you under any Company employment agreement (oral or written) or Company policy or practice, and that this Severance Pay to be provided to you is not intended to, and shall not constitute, a severance plan, and shall confer no benefit on
anyone other than the parties hereto. You further acknowledge that except for the specific financial consideration set forth in this Agreement, you are not and shall not in the future be entitled to any other compensation including, without
limitation, wages, bonuses, vacation pay, holiday pay or any other form of compensation or benefit. 
  
 3. Unemployment Benefits. The Company agrees that it will not contest any claim for unemployment benefits by you with the State of Utah. The
Company, of course, shall not be required to falsify any information. 
  
 4. Cooperation. You agree that both during and at any time after your employment, you shall cooperate fully with the Company in connection with any matter or event relating to your employment or events that occurred during
your employment, including, without limitation, in the defense or prosecution of any claims or actions now in existence or which may be brought or threatened in the future against or on behalf of the Company, including any claims or actions against
its affiliates and its and their officers and employees. Your cooperation in connection with such matters, actions and claims shall include, without limitation, being available, upon reasonable notice to meet with the Company regarding matters in
which you have been involved, and any contract matters or audits; to prepare for, attend and participate in any proceeding (including, without limitation, depositions, consultation, discovery or trial); to provide affidavits; to assist with any
audit, inspection, proceeding or other inquiry; and to act as a witness in connection with any litigation or other legal proceeding affecting the Company. You further agree that should you be contacted (directly or indirectly) by any person or
entity (for example, by any party representing an individual or entity) adverse to the Company, you shall promptly notify me or Reyn Gallacher. You shall be reimbursed for any reasonable costs and expenses incurred in connection with providing such
cooperation under this section. 
  
 5. Additional Covenants
by You. You expressly acknowledge and agree to the following: 
  
 (i) that prior to the termination of your employment, you shall return to the Company all Company documents (and any copies thereof) and property, and that you will abide by any and all common law and/or statutory obligations relating to
protection and nondisclosure of the Company’s trade secrets and/or confidential and proprietary documents and information; 
  
 (ii) that all information relating in any way to the negotiation of this Agreement, including the terms and amount of financial consideration provided for
in this Agreement, shall be held confidential by you and shall not be publicized or disclosed to any person (other than an immediate family member, legal counsel or financial advisor, provided that any such individual to whom disclosure is made
agrees to be bound by these confidentiality obligations), business entity or government agency (except as mandated by state or federal law); 
  

 2 

 (iii) that you will not make any statements that are professionally or personally disparaging about, or
adverse to, the interests of the Company (and its officers, directors and managers) including, but not limited to, any statements that disparage any such person, product, service, finances, financial condition, capability or any other aspect of the
business of the Company, and that you will not engage in any conduct which is intended to harm professionally or personally the reputation of the Company (and its officers, directors and managers); 
  
 (iv) that the breach of any of the foregoing covenants by you shall
constitute a material breach of this Agreement and shall relieve the Company of any further obligations hereunder and, in addition to any other legal or equitable remedy available to the Company, shall entitle the Company to recover any Severance
Pay already paid to you pursuant to Section 2 of this Agreement. 
  
 6. Release of Claims. You hereby agree and acknowledge that by signing this Agreement
and accepting the Severance Pay to be provided to you, and other good and valuable consideration provided for in this Agreement, you, except as expressly provided below, are waiving and releasing your right to assert any form of legal claim against
the Company1/ whatsoever for any alleged action, inaction or circumstance existing or arising from the beginning of
time through the Effective Date. Your waiver and release herein, except as expressly provided below, is intended to bar any form of legal claim, charge, complaint or any other form of action (jointly referred to as “Claims”) against the
Company seeking any form of relief including, without limitation, equitable relief (whether declaratory, injunctive or otherwise), the recovery of any damages or any other form of monetary recovery whatsoever (including, without limitation, back
pay, front pay, compensatory damages, emotional distress damages, punitive damages, attorneys fees and any other costs) against the Company, for any alleged action, inaction or circumstance existing or arising through the Effective Date. 

 
 Without limiting the foregoing general waiver and release, you, except as
expressly provided below, specifically waive and release the Company from any Claim arising from or related to your employment relationship with the Company or the termination thereof, including, without limitation: 
  

	 	 1/
	 	 For the purposes of this section, the parties agree that the term “Company” shall include
Amedica Corporation, its divisions, affiliates and subsidiaries, and its and their respective officers, directors, employees, attorneys, agents and assigns. 

  

 3 

	 	•	 	 Claims under any state or federal discrimination, fair employment practices or other employment related statute, regulation or executive order (as they may have
been amended through the Effective Date) prohibiting discrimination or harassment based upon any protected status including, without limitation, race, national origin, age, gender, marital status, disability, veteran status or sexual orientation.
Without limitation, specifically included in this paragraph are any Claims arising under the federal Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, the Civil Rights Acts of 1866 and 1871, Title VII of the Civil
Rights Act of 1964, the Civil Rights Act of 1991, the Equal Pay Act, the Americans With Disabilities Act and any similar or other state statute. 

  

	 	•	 	 Claims under any other state or federal employment related statute, regulation or executive order (as they may have been amended through the Effective Date)
relating to wages, hours or any other terms and conditions of employment. Without limitation, specifically included in this paragraph are any Claims arising under the Fair Labor Standards Act, the National Labor Relations Act, the Employee
Retirement Income Security Act of 1974, the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA) and any similar or other state statute. 

  

	 	•	 	 Claims under any state or federal common law theory including, without limitation, wrongful discharge, breach of express or implied contract, promissory estoppel,
unjust enrichment, breach of a covenant of good faith and fair dealing, violation of public policy, defamation, interference with contractual relations, intentional or negligent infliction of emotional distress, invasion of privacy,
misrepresentation, deceit, fraud or negligence. 

  

	 	•	 	 Any other Claim arising under local, state or federal law. 

  
 You explicitly acknowledge that because you are over forty (40) years of age, you have specific rights under the Older
Workers Benefits Protection Act (“OWBPA”), which prohibits discrimination on the basis of age, and that the releases set forth in this section are intended to release any right that you may have to file a claim against the Company alleging
discrimination on the basis of age. 
  
 Notwithstanding the
foregoing, this section does not: 
  

	 	•	 	 release the Company from any obligation expressly set forth in this Agreement or from any obligation, including without limitation obligations under the Workers
Compensation laws, which as a matter of law cannot be released; 

  

	 	•	 	 prohibit you from filing a charge with the Equal Employment Opportunity Commission (“EEOC”); 

  

	 	•	 	 prohibit you from participating in an investigation or proceeding by the EEOC or any comparable state or local agency; or 

  

 4 

	 	•	 	 prohibit you from challenging or seeking a determination in good faith of the validity of this release or waiver under the Age Discrimination in Employment Act and
does not impose any condition precedent, penalty, or costs for doing so unless specifically authorized by federal law. 

  
 Your waiver and release, however, are intended to be a complete bar to any recovery or personal benefit by or to you with respect to any claim whatsoever,
including those raised through a charge with the EEOC, except those which, as a matter of law, cannot be released. In the event that you successfully challenge the validity of the release with respect to the Age Discrimination in Employment Act, the
Company or any affected party sought to be released hereunder may seek recovery from you of all amounts paid pursuant to this Agreement. Nothing in this Agreement, however, shall limit the right of the Company or any affected party sought to be
released hereunder to seek immediate dismissal of a charge on the basis that your signing of this Agreement constitutes a full release of any rights you might otherwise have to pursue the charge. 
  
 You acknowledge and agree that, but for providing this waiver and release,
you would not be receiving the Severance Pay being provided to you under the terms of this Agreement. 
  
 It is the Company’s desire and intent to make certain that you fully understand the provisions and effects of this Agreement. To that end, you have
been encouraged and given the opportunity to consult with legal counsel for the purpose of reviewing the terms of this Agreement. Consistent with the provisions of OWBPA, the Company is providing you with twenty-one (21) days in which to
consider and accept the terms of this Agreement by signing below and returning it to Ashok Khandkar, Amedica Corporation, 615 Arapeen Drive, Suite 302, Salt Lake City, UT 84108. In addition, you must rescind your assent to this Agreement within
seven (7) days after you sign it. To do so, you must deliver a notice of rescission to Ashok Khandkar. To be effective, such rescission must be hand delivered or postmarked within the seven (7) day period and sent by certified mail, return
receipt requested, to Ashok Khandkar, Amedica Corporation, 615 Arapeen Drive, Suite 302, Salt Lake City, UT 84108, 
  
 7. Entire Agreement/Modification/Waiver/Choice of Law/Enforceability/Jury Waiver. You acknowledge and agree that, with the exception
of your Confidentiality and Assignment of Inventions Agreement, your so called “lock-up” agreement dated May 26, 2006, the Amended and Restated Registration Rights Agreement among the Company and certain of its securityholders, any
restrictive covenants relating to your employment, this Agreement supersedes any and all prior or contemporaneous oral and/or written agreements between you and the Company, and sets forth the entire agreement between you and the Company. No
variations or modifications hereof shall be deemed valid unless reduced to writing and signed by the parties hereto. The failure of the Company to seek enforcement of any provision of this Agreement in any instance or for any period of time shall
not be construed as a waiver of such provision or the Company’s right to seek enforcement of such provision in the future. This Agreement shall be deemed to have been made in the State of Utah, shall take effect as an instrument under seal
within Utah, and shall be governed by and construed in accordance with the laws of the State of Utah, without giving effect to conflict of law principles. You agree that any action, demand, claim or counterclaim relating to the terms and provisions
of this Agreement, or to its formation 

  

 5 

 
or breach, shall be commenced in Salt Lake City, Utah in a court of competent jurisdiction, and you further acknowledge that venue for such actions shall lie
exclusively in Utah and that material witnesses and documents would be located in Utah. Both parties hereby waive and renounce in advance any right to a trial by jury in connection with such legal action. The provisions of this Agreement are
severable, and if for any reason any part hereof shall be found to be unenforceable, the remaining provisions shall be enforced in full. 
  
 By executing this Agreement, you are acknowledging that you have been afforded sufficient time to understand the terms and effects of this Agreement, that
your agreements and obligations hereunder are made voluntarily, knowingly and without duress, and that neither the Company nor its agents or representatives have made any representations inconsistent with the provisions of this Agreement.

  
 This Agreement may be signed on one or more copies, each of
which when signed will be deemed to be an original, and all of which together will constitute one and the same Agreement. 
  
 If the foregoing correctly sets forth our understanding, please sign, date and return the enclosed copy of this Agreement to me at the Company within
twenty-one (21) days. 
  

			
	 Very truly yours,
  
 AMEDICA CORPORATION

		
	 By:
	 	/s/ Ashok Khandkar
		 	Ashok Khandkar,
		 	Chief Executive Officer
	
	 Dated: January 5, 2007

  

	
	Confirmed and Agreed:
	
	/s/ Eugene B. Jones
	Eugene B. Jones

  
 Dated: January 5, 2007 
  

 6Letter Agreement with Creation Capital LLC dated November 14, 2005

 Exhibit 10.24 
  
 EXECUTION COPY 
  
 CREATION CAPITAL LLC 
  
 November 14, 2005 
  
 PERSONAL & CONFIDENTIAL 
  
 Mr. Ashok Khandkar 
 Chief Executive Officer 
 Amedica Corporation 
 615 Arapeen 
 Suite 302 
 Salt Lake City, Utah 84108 
  
 Dear Ashok: 
  
 This letter will confirm the agreement under which Amedica Corporation (the “Company”) engages Creation Capital LLC (“Creation
Capital”) as the exclusive placement agent for the Company. 
  
 1. Private Placement Engagement 
  
 A. Scope
of Engagement. The Company hereby engages Creation Capital as the Company’s exclusive placement agent during the term of this agreement (the “Agreement”) in connection with the proposed private placement of securities of the
Company (the “Offering”). Creation Capital hereby accepts such engagement on the terms and conditions set forth herein. It is currently contemplated that the Offering will be structured as a best-efforts private offering of a minimum of
$3,000,000 and a maximum of $14,000,000 of Series C Convertible Preferred Stock of the Company (the “Stock”) at a price of $2.00 per share (the “Offering Price”), plus a 20% ($2,800,000) overallotment option to Creation Capital.
The Stock will have the terms substantially as set forth in Appendix I, attached hereto. However, as you know, the final terms of the Offering may be negotiated between the Company and the investors who purchase the Stock in the Offering, and
will be set forth in a definitive agreement to be executed by the Company and the investors. This Agreement shall not give rise to any commitment by Creation Capital to purchase any of the Stock, and Creation Capital shall have no authority to bind
the Company with respect to the sale of the Stock. 
  
 B.
Services. Creation Capital will perform the following services in connection with the Offering: 
  
 a) review the Company’s current business operations, prospects and projected financial results and such other matters as Creation Capital deems
relevant to enable it to render financial advice and assistance to the Company; 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant
to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 b) assist the Company and its counsel in the preparation and review of a private placement memorandum and related documents;

  
 c) identify and contact potential investors; and 

 
 d) establish an appropriate escrow account to facilitate the closing(s) of
sale(s) of the Stock pursuant to the Offering. 
  
 C. Term of
Engagement. The term of this Agreement shall extend until the earlier of (i) sale of all of the Stock pursuant to the Offering or (ii) 90 days from the date of Creation Capital’s receipt of the final printed Memorandum (as defined
below), which period shall be automatically extended until the closing with respect to any subscriptions for investment that have been accepted by the Company prior to such date. The exclusive period may be extended by mutual consent. Upon
expiration of this Agreement, any accrued fees and unreimbursed expenses will be immediately due and payable by the Company to Creation Capital. If the Company terminates the Offering prior to the end of the period set forth in the first sentence of
this section, does not accept subscriptions from investors that have been properly entered into, or otherwise violates any of its obligations under this Agreement, and subsequently at any time during the one (1) year period following the
expiration or termination of the Offering the Company completes a private placement or sells equity or debt securities (other than pursuant to a public offering, to officers and directors of the Company, in connection with the hiring or compensation
of employees, consultants or directors, or in connection with a strategic alliance or similar agreement), then Creation Capital shall be entitled to receive, and the Company shall be obligated to pay to Creation Capital, the fees (both the cash and
warrant components) set forth in Sections 2(A) and 2(B) below with respect to the securities sold in such offerings or sales. 
  
 D. Offering Memorandum. The Offering will be made by means of a private placement memorandum (the “Memorandum”), to be prepared and
approved by the Company and its counsel. The Company will also be responsible for updating and supplementing the Memorandum prior to any sale of the Stock pursuant to the Offering to reflect developments and changes affecting the Company. The
Memorandum and any amendment or supplement thereto will be in a form reasonably acceptable to Creation Capital and its counsel. The Company agrees that Creation Capital will rely, without independent verification, on the information contained in the
Memorandum and shall have no responsibility for any information contained therein. All other documents and materials to be used for circulation to investors (collectively, “Investor Materials”) in connection with the Offering will be
provided by the Company to Creation Capital in advance, and no such documents or materials will be provided to investors without Creation Capital’s prior approval. Creation Capital shall not provide to investors any information about the
Company other than Investor Materials that both Creation Capital and the Company have approved. Except as provided in the next sentence, the Memorandum and all Investor Materials shall be the sole responsibility of the Company. Subject to the
Projections Qualification (defined below), neither the Memorandum nor any of the Investor Materials shall contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, except that the Company shall not be responsible for any information 

  

 2 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 
concerning Creation Capital supplied by Creation Capital in writing to the Company for inclusion therein, which information shall be governed by the same
standard but for which Creation Capital shall be responsible. 
  
 E. Compliance with Securities Laws. Each of the Company and Creation Capital agrees to conduct the Offering in a manner intended to qualify for the exemption from the registration requirements of the Securities Act of 1933, as
amended (the “Securities Act”), available pursuant to Regulation D thereunder. Each of the Company and Creation Capital agrees to limit offers to sell, and solicitations of offers to buy, the Stock in connection with the Offering to
persons reasonably believed by it to be “accredited investors” within the meaning of Rule 501(a) under the Securities Act. Each of the Company and Creation Capital agrees that it will not engage in any form of general solicitation or
general advertising in connection with the Offering within the meaning of Rule 502(c) under the Securities Act. Each of the Company and Creation Capital agrees to conduct the Offering in a manner intended to comply with the registration or
qualification requirements, or available exemptions therefrom, under applicable state “blue sky” laws and applicable securities laws of other jurisdictions in which the Company and Creation Capital agree that offers and sales will be made.
None of the Company, Creation Capital nor any person acting on their respective behalf has, prior to the date hereof, taken any action which, if taken after the date hereof, would constitute a violation of the preceding four sentences. The Company
shall be responsible for compliance with the filing requirements of the securities laws of states and other jurisdictions and in that respect shall provide to Creation Capital a “blue sky” memorandum and shall make all filings and take all
other actions as are required in connection with compliance with such laws. The Company will not, for a period of six (6) months following the final closing date under the Offering, offer for sale or sell securities in a transaction the primary
purpose of which is to raise capital for the Company unless, in the opinion of the Company’s legal counsel, concurred with by Creation Capital’s legal counsel, such offer or sale does not jeopardize the availability of exemptions from the
registration and the qualification requirements under applicable federal securities laws, state “blue sky” laws or the securities laws of any other jurisdiction with respect to the Offering. 
  
 2. Fees and Expenses 
  
 A. Placement Agent Fee. Upon execution of this agreement, the Company
will pay Creation Capital a refundable retainer of $75,000. This retainer will be applied to the fee to be paid to Creation Capital at the first closing of the sale of the Stock as described below. From time to time, upon the closing of the sale of
the Stock, the Company agrees to pay Creation Capital a placement agent fee equal to nine percent (9%) of the gross proceeds of all sales of Stock pursuant to the Offering. Fees payable pursuant to this section shall be due whether or not the
investors were introduced to or contacted on behalf of the Company by Creation Capital; provided, however, the foregoing fees shall not apply to any investment by (i) any officer of the Company or member of the Company’s Board of
Directors, or (ii) any entity listed on Exhibit B hereto (all such investors described in clauses (i) and (ii) being hereinafter referred to as “Company-Related Investors”). Such fees shall be payable in cash; and
provided, further, that Creation Capital shall, in its sole discretion, have the right to elect to receive any or all of the placement agent fees in shares of Stock, the value of which shares will be calculated on the basis of the Offering
Price. Creation Capital shall be entitled, but shall not be obligated, to purchase Stock sold in the Offering on the same terms and conditions as the other purchasers in the Offering. 
  

 3 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 B. Warrants. From time to time, upon the closing of the sale of Stock, Creation Capital shall receive (in addition to
the fee set forth in Section 2.A. above) warrants to purchase a number of shares of Stock equal to fifteen percent (15%) of the total number of the shares of Stock sold in the Offering; provided, however, the foregoing warrant
coverage shall not apply to any investment by any Company-Related Investors. The warrants (a) will be exercisable for a period of seven-years from the date of the final closing of the sale of Stock pursuant to the Offering, (b) will have
an exercise price equal to 110% of the price per share of Stock in the Offering and (c) will be exercisable on the earlier of (i) one (1) year from the date of final sale of shares of Stock pursuant to the Offering, (ii) the
consummation of a registered public offering or (iii) the consummation of a merger of the Company with or into another entity, acquisition of the outstanding capital stock of the Company, sale of the Company’s assets, or recapitalization
as a result of which the Company’s stockholders immediately prior to such transaction hold less than 50% of the voting power of the surviving corporation immediately after such transaction, or more than 50% of the assets of the Company are
transferred or sold. The warrants shall be issued pursuant to a definitive warrant agreement containing customary provisions including registration rights, anti-dilution provisions which comply with NASD or other applicable exchange or regulatory
requirements, and a cashless exercise provision. 
  
 C.
Expenses. The Company agrees to pay Creation Capital (i) upon each closing of the sale of Stock one percent (1%) of the amount of gross proceeds from the sale of Stock pursuant to the Offering for non-accountable expenses, up to a
maximum of $140,000, plus (ii) reasonable fees and expenses of legal counsel up to $35,000, $20,000 of which shall be payable to Creation Capital’s counsel as a retainer upon execution of this Agreement. The Company agrees to pay up front
all reasonable expenses incurred as a result of marketing purposes, including the printing of the Memorandum and the Investor Materials, renting of facilities for any presentations, and travel expenses, it being agreed that any such expenses
incurred by Creation Capital in conducting the Offering shall be creditable against the $140,000 above unless such expenses relate to the Company’s travel and participation in the Offering, which expenses shall be entirely borne by the Company.

  
 D. Related Transactions. (a) To the extent that
any purchaser (or its affiliate) in the Offering (other than any current stockholder of the Company, except for purposes of this clause only, any investor in Series A Convertible Preferred Stock and Series B Convertible Preferred Stock of the
Company), purchases any other equity or debt securities of the Company from the Company in a private sale during the twelve (12) month period following the closing of such purchaser’s last purchase of Stock in the Offering, Creation
Capital shall be entitled to receive with respect to such subsequent sale the fees (both the cash and warrant components) as set forth in Sections 2.A. and 2.B. hereof. Notwithstanding the foregoing, Creation Capital shall not be entitled to receive
any fees pursuant to this Section 2.D. with respect to sales of securities by the Company to any Company-Related Investor, except in the event of a Change of Control (as defined below). 
  

 4 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 (b) If the Company receives an Acquisition Proposal, a transaction pursuant to such Acquisition Proposal is completed at
tiny time prior to a registered public offering of the securities of the Company and Creation raises at least $7,000,000 in the Offering, then Creation Capital will be entitled to a “Transaction Fee” as set forth below. An
“Acquisition Proposal” shall be any proposal to acquire capital stock of the Company, directly or indirectly, any merger proposal, tender offer, recapitalization or asset sale pursuant to which the Company’s stockholders immediately
prior to such transaction hold less than 50% of the voting power of the surviving corporation immediately after such transaction or the majority of the assets of the Company are transferred or sold. A “Change of Control” shall mean any
consummation of the Acquisition Proposal. 
  
 If a Change of
Control is completed and Creation raises at least $7,000,000 in the Offering, Creation Capital shall be paid a “Transaction Fee” equal to (i) three percent (3%) of the Aggregate Transaction Value if the Aggregate Transaction
Value is up to $50,000,000, (ii) two percent (2%) of the Aggregate Transaction Value if the Aggregate Transaction Value is more than $50,000,00 but less than $100,000,000, and (iii) one and a half percent (1.5%) of the Aggregate
Transaction Value if the Aggregate Transaction Value is more than $100,000,000; provided, however, that in any event the Transaction Fee shall not exceed $2,500,000. “Aggregate Transaction Value” shall be defined to include, without
limitation, all cash, securities, notes and other consideration paid, directly or indirectly, by the acquiring entity, plus any debt assumed. The fees determined under the terms of this Agreement shall be due and payable in cash via wire transfer at
closing. Any portion of such Transaction Fee attributable to consideration to be paid to the Company and/or its stockholders after the closing of such transaction shall be payable to Creation Capital at the time such consideration is received by the
Company and/or its stockholders. If the Aggregate Transaction Value or a portion thereof is in the form of publicly traded debt or equity securities, then the amount of the Aggregate Transaction Value will be based on the fair market value of such
securities determined as of the closing date. If the securities are not publicly traded, the fair market value of such securities will be determined by the terms of the final acquisition agreement to be negotiated in good faith between the Company
and the acquiring company. 
  
 3. Due Diligence 

 
 A. Due Diligence and Company Material. The Company shall make
members of management, employees and advisors reasonably available to Creation Capital for purposes of satisfying Creation Capital’s due diligence requirements and consummating the Offering, and shall commit such time and other resources as are
reasonably necessary or appropriate to secure timely success of the Offering. The Company shall cooperate with Creation Capital in connection with, and shall make available to Creation Capital, data, material and other information as Creation
Capital shall reasonably request to satisfy its due diligence requirements. Creation Capital will be entitled to rely on and use such data, material and other information that is publicly available without independent verification thereof. From and
after the date of this Agreement during the term hereof, the Company shall provide to Creation Capital, if prepared regularly by the Company, monthly balance sheets, income statements, statements of cash flows and other financial information as soon
as available following the closing of each month and shall otherwise inform Creation Capital of any material events or 

  

 5 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 
developments or potential material events affecting the Company at any point during the term of the engagement. None of the documents or other information
prepared by the Company provided to Creation Capital, including those in the Memorandum and the Investor Documents, shall contain an untrue statement of a material fact or omit to state a material fact necessary to make any such statements, in light
of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, with respect to the projections provided by the Company for inclusion in the offering documents, the Company represents only that they have been prepared
based upon assumptions which the Company believes to be reasonable based on facts now known to it (this exception from the foregoing being referred to as the “Projections Qualification”). Following any closing pursuant to the Offering, the
Company shall, for a period of three years, provide to Creation Capital all information made available either to purchasers in the Offering or to the Company’s stockholders generally. 
  
 B. Confidentiality. Creation Capital will keep confidential and not
disclose to any third party any confidential information of the Company made available to Creation Capital pursuant to Section 3(A) hereof by the Company, and will use the confidential information only in connection with the engagement
hereunder; provided, however, such confidential information shall not include any information already available to or in the possession of Creation Capital prior to the date of its disclosure to Creation Capital by the Company, any
information in the Memorandum or the Investor Materials which is generally available to the public, or any information which becomes available to Creation Capital on a non-confidential basis from a third party that is not bound by a confidentiality
obligation to the Company, and provided, further, that such confidential information may be disclosed (i) to Creation Capital’s partners, employees, agents, advisors and representatives in connection with its engagement
hereunder, who shall be informed of the confidential nature of the information and that such information is subject to a confidentiality agreement; (ii) to any person with the consent of the Company, including to any prospective investors;
(iii) if Creation Capital is required to disclose such information pursuant to law, judicial or administrative process or regulatory demand or request; or (iv) if such disclosure is deemed necessary by Creation Capital in litigation or any
other proceeding in which it or any of its current or former directors, officers, employees, agents, representatives, affiliates or any person who controls Creation Capital is, or is threatened to be made, a party; provided, however, that, in
connection with any disclosure pursuant to clauses (iii) or (iv) of this Section 3.B., Creation Capital shall provide prior notice to the Company and shall use commercially reasonable efforts to limit the disclosure to the minimum
amount necessary under the circumstances, including obtaining judicial protective orders regarding the Company’s confidential information. This subparagraph supersedes any prior agreement between the Company and Creation Capital with respect to
confidentiality. 
  
 C. Legal Opinion. The Company will, at
each closing pursuant to the Offering, furnish Creation Capital with an opinion of its counsel relating to the Company and the Offering in form and substance reasonably satisfactory to Creation Capital and its counsel. In addition, at each closing
pursuant to the Offering, the Company will provide Creation Capital with the same certificates of the officers of the Company and other documents and certificates as are furnished to the purchasers in the Offering and such other certification and
documents as Creation Capital or its counsel may reasonably request, in form and substance reasonably satisfactory to Creation Capital and its counsel. 
  

 6 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 4. Representations and Warranties of the Company. The Company represents and warrants to, and agrees with, Creation
Capital that (a) the Company and its subsidiaries have been duly organized and are validly existing as corporations under their jurisdictions of incorporation; (b) this Agreement constitutes a valid and binding obligation of the Company,
except as the indemnification and contribution obligations hereof may be limited by principles of equity or by public policy; and (c) subject to the Projections Qualification, the Memorandum as amended and supplemented does not contain and will
not at any time prior to the closing date contain, and on the closing date no information supplied by the Company to any prospective investor (directly or through Creation Capital) will contain, an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
  
 5. Representations of Creation Capital. Creation Capital represents and warrants to, and agrees with, the Company that (a) Creation Capital is
a member in good standing of the National Association of Security Dealers and registered as a broker/dealer under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”); (b) Creation Capital has the requisite power
to enter and perform the Agreement; (c) the Agreement has been duly authorized by Creation Capital and, upon execution by the Company, will become binding on Creation Capital; (d) all information supplied by Creation Capital in writing is
correct in all material aspects; and (e) Creation Capital will not give investors or potential investors any information that is not described in Section 3 (A). 
  
 6. Indemnification. Creation Capital and the Company hereby agree to the indemnification and contribution provisions
set forth in Exhibit A hereto, which is incorporated herein by reference and is part of the Agreement. The indemnification provisions of Exhibit A shall survive any termination of this Agreement. Capitalized terms not otherwise defined
therein shall have the meanings set forth in the Agreement. 
  
 7. Miscellaneous 
  
 A. Notices. All
notices or communications hereunder will be in writing and will be mailed or delivered as follows: if to the Company, at the name and address set forth on this first page of this Agreement, facsimile number (801) 583-8635; with a copy to Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111, Attention: Jonathan L. Kravetz, Esq., facsimile number (617) 542-2241; and if to Creation Capital, at 100 Congress Avenue, Suite 2000, Austin, Texas 78701,
Attention: Gregg R. Honigblum, facsimile number: (512) 473-4903; with a copy to Winston & Strawn LLP, 200 Park Avenue, New York, NY 10166, Attention: Nikolai Krylov, Esq., facsimile number (212) 294-4700. 
  
 B. No Third Party Rights. The Company acknowledges and agrees that
Creation Capital has been retained to act solely as agent to the Company, and not as an agent of any other person, and the Company’s engagement of Creation Capital is not intended to confer rights upon any person not a party hereto (including
shareholders, employees or creditors of the Company) as against Creation Capital or its affiliates, or their respective directors, officers, employees or agents, successors or assigns. Creation Capital shall act as an independent contractor under
this Agreement, and any duties arising out of its engagement shall be owed solely to the Company. 
  

 7 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 C. Confidentiality. Except to the extent legally required (after consultation with Creation Capital and its counsel),
none of (i) the name of Creation Capital, (ii) any advice rendered by Creation Capital to the Company or (iii) any communication from Creation Capital in connection with the services performed by Creation Capital pursuant to this
Agreement will be quoted or referred to orally or in writing or, in the case of (ii) or (iii), reproduced or disseminated by the Company or any of its affiliates or any of their agents, without Creation Capital’s prior written consent.

  
 D. Survival; Governing Law; Entire Agreement. The
representations, warranties and covenants of the Company set forth herein will remain in full force and effect regardless of any investigation made by or on behalf of Creation Capital, any investor or any other entity or persons and will survive
delivery of the Stock. The provisions of this Section 7 and Sections 1.C., 2, 3.A., 3.B., 4 and 5 hereof shall survive any termination of this Agreement and the offering, sale and delivery of the Stock for a period of three (3) years
following the earlier of the final delivery of the Stock or the termination of this Agreement, as applicable. This Agreement, and any claim, counterclaim or dispute of any kind or nature whatsoever arising out of in any way relating to this
Agreement (“Claim”), directly or indirectly, shall be governed by and construed in accordance with the internal laws of the State of New York, regardless of the conflict of law principles. Except as set forth below, no Claim may be
commenced, prosecuted or continued in any court other than the courts of the State of New York located in the City and County of New York or in the United States District Court of the Southern District of New York, which courts shall have exclusive
jurisdiction over the adjudication of such matters, and the Company and Creation Capital consent to the jurisdiction of such courts and personal service with respect thereto. The Company hereby consents to personal jurisdiction, service and venue in
any court in which any Claim is brought by any third party against Creation Capital or any indemnified party arising out of the Offering. Each of Creation Capital and the Company waives all right to trial by jury in any Claim brought by the other
(whether based upon contract, tort or otherwise). The Company agrees that a final judgment in any such Claim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts in the jurisdiction of
which the Company is or may be subject, by suit upon such judgment. This Agreement contains the entire agreement between the Company and Creation Capital concerning the Offering, unless subsequently amended in a writing signed by both parties, and
supersedes any prior understanding or agreement whether written or oral. Any amendment hereto or waiver of any right or obligation hereunder must be in writing signed by the party to be charged. Neither party may assign any of its obligations and
responsibilities hereunder without the written consent of the other party. This Agreement shall be binding upon the Company and Creation Capital and their respective successors and permitted assigns and any successor or assign of any substantial
portion of the Company’s and Creation Capital’s respective businesses and/or assets. 
  
 This Agreement is effective as of the date first set forth above. Please confirm that the foregoing correctly sets forth our understanding, by signing and returning to us the enclosed duplicate of this Agreement.

  

 8 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  

			
	Sincerely,
	
	CREATION CAPITAL LLC
		
	By:	 	 /s/ Gregg R. Honigblum

	Name:	 	Gregg R. Honigblum
	Title:	 	Chief Executive Officer

  

			
	 Accepted and agreed
 as of the date first
written above:

	
	AMEDICA CORPORATION
		
	By:	 	 /s/ Ashok Kharndkar

		 	Ashok Khandkar
		 	Chief Executive Officer

  

 9 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 EXHIBIT A 
  
  
 Indemnification and Contribution 
  
 Indemnification by the Company. 
  
 The Company agrees to indemnify and hold harmless Creation Capital, its
affiliates, and each of their respective affiliates, directors, officers, agents, advisors, consultants, employees and controlling persons (as defined in Section 15 of the Securities Act of 1933 and Section 20 (a) of the Exchange Act)
(Creation Capital and each such other person or entity are hereinafter referred to as “Creation Capital Indemnified Person”), from and against any losses, claims, damages, reasonable expenses and liabilities or actions in respect thereof
(collectively, “Losses”) as they may be incurred, including all legal fees and other expenses incurred in connection with investigating, preparing, defending, paying, settling or compromising any Losses, whether or not in connection with
any pending or threatened litigation in which any Creation Capital Indemnified Person is a named party, to which any of them may become subject (including in any settlement effected with the Company’s consent, which shall not be unreasonably
withheld) and which are related to or arise out of any act or omission of the Company contemplated by or related to the Agreement. The Company will not, however, be responsible under the foregoing provisions with respect to any Losses to the extent
that a court of competent jurisdiction shall have determined by a final, non-appealable judgment that such Losses resulted from a Creation Capital Indemnified Person’s gross negligence or bad faith. 
  
 If the indemnity referred to in this Exhibit A should be, for any reason
whatsoever, unenforceable, unavailable or otherwise insufficient to hold each Creation Capital Indemnified Person harmless for all Losses incurred by it, the Company shall pay to or on behalf of each Creation Capital Indemnified Person contributions
for Losses so that each Creation Capital Indemnified Person ultimately bears only such portion of such Losses as is appropriate (i) to reflect the relative benefits received by each such Creation Capital Indemnified Person, respectively, on the
one hand and the Company on the other hand in connection with the transactions contemplated by the Agreement or (ii) if the allocation on that basis is not permitted by applicable law, to reflect not only the relative benefits referred to in
clause (i) above but also the relative fault of each such Creation Capital Indemnified Person, respectively, and the Company as well as any other relevant equitable considerations; provided, however, that in no event shall the aggregate
contribution of all Creation Capital Indemnified Persons to all Losses exceed the amount of the fees actually received by Creation Capital pursuant to the Agreement. The respective relative benefits received by Creation Capital and the Company in
connection with any Offering shall be deemed to be in the same proportion as the aggregate fee paid to Creation Capital in connection with the Offering bears to the gross proceeds of the Offering. The relative fault of each Creation Capital
Indemnified Person and the Company shall be determined by reference to, among, other things, whether the actions or omissions to act were by such Creation Capital Indemnified Person or the Company, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or present such action or omission to act. The Company and Creation Capital agree that it would not be just and equitable if contributions were determined by pro rata allocation or by any other method
of allocation which does not take account of the equitable contributions referred to above. 
  

 10 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 The Company also agrees that no Creation Capital Indemnified Person shall have any liability to the Company or its
affiliates, directors, officers, employees, agents, advisors or shareholders, directly or indirectly, related to or arising out of the Agreement, except Losses incurred by the Company that a court of competent jurisdiction shall have determined by a
final, non-appealable judgment to have resulted from such Creation Capital Indemnified Person’s gross negligence or bad faith. In no event, regardless of the legal theory advanced, shall any Creation Capital Indemnified Person be liable for any
consequential, indirect, incidental, punitive or special damages of any nature. 
  
 Promptly after receipt by any Creation Capital Indemnified Person of notice of any pending or threatened litigation, such Creation Capital Indemnified Person will promptly notify the Company in writing of such matter;
provided, however, that the failure to provide such prompt notice to the Company shall not relieve the Company of any liability which it may have to such Creation Capital Indemnified Person unless such failure to provide such prompt notice to
the Company has materially prejudiced the defense of the litigation. In the event any such action is brought against any Creation Capital Indemnified Person, the Company shall be entitled to participate therein and to assume the defense thereof,
with counsel reasonably satisfactory to the Creation Capital Indemnified Person, unless, however, the Creation Capital Indemnified Person reasonably determines that defenses may be available to the Creation Capital Indemnified Person that are not
available to the Company and/or may not be consistent with the best interest of the Company. In such event, the Creation Capital Indemnified Person shall have the right to assume its own defense, with counsel reasonably satisfactory to the Company,
and shall so signify by promptly notifying the Company in writing of its decision. Such decision shall not relieve the Company of any liability which it may have to the Creation Capital Indemnified Person, including the reimbursement of reasonable
legal fees or other expenses incurred in connection with the Creation Capital Indemnified Person’s defense. The Company shall not, without the prior written consent of the Creation Capital Indemnified Person, effect any settlement of, consent
to the entry of any judgment in, or otherwise seek to terminate any pending or threatened proceeding arising out of or relating to the engagement, unless such settlement includes an express, unconditional release of such Creation Capital Indemnified
Person from all liabilities asserted, or potential claims, against the Creation Capital Indemnified Person. The Company shall not be liable for any settlement Creation Capital enters into without the Company’s consent, which consent shall not
be unreasonably withheld. 
  
 Indemnification by Creation
Capital. 
  
 In consideration of the Agreement, Creation
Capital agrees to indemnify and hold harmless the Company, its affiliates, and each of their respective affiliates, directors, officers, agents, advisors, consultants, employees and controlling persons (the Company and each such other person or
entity are hereinafter referred to as a “Company Indemnified Person”), from and against any Losses as they may be incurred, including all legal fees and other expenses incurred in connection with investigating, preparing, defending,
paying, settling or compromising any Losses, whether or not in connection with any pending or threatened litigation in which any Company Indemnified Person is a named party, to which any of them may become subject (including in any settlement
effected with the Creation Capital’s consent, which shall not be unreasonably withheld) with respect to the information provided in writing by Creation Capital 

  

 11 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 
to the Company specifically for inclusion in the Memorandum, and which information the Company eluded in the Memorandum. Creation Capital will not, however,
be responsible under the foregoing provisions with respect to any Losses to the extent that a court of competent jurisdiction shall have determined by a final, non-appealable judgment that such Losses resulted from a Company Indemnified
Person’s gross negligence or bad faith. 
  
 If the indemnity
referred to in this Exhibit A should be, for any reason whatsoever, unenforceable, unavailable or otherwise insufficient to hold each Company Indemnified Person harmless for all Losses incurred by it, Creation Capital shall pay to or on behalf of
each Company Indemnified Person contributions for Losses so that each Company Indemnified Person ultimately bears only such portion of such Losses as is appropriate (i) to reflect the relative benefits received by each such Company Indemnified
Person, respectively, on the one hand and Creation Capital on the other hand in connection with the transactions contemplated by the Agreement or (ii) if the allocation on that basis is not permitted by applicable law, to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of each such Company Indemnified Person, respectively, and Creation Capital as well as any other relevant equitable considerations. The respective relative benefits
received by Creation Capital and the Company in connection with any Offering shall be deemed to be in the same proportion as the aggregate fee paid to Creation Capital in connection with the Offering bears to the gross proceeds of the Offering. The
relative fault of each Company Indemnified Person and Creation Capital shall be determined by reference to, among, other things, whether the actions or omissions to act were by such Company Indemnified Person or Creation Capital, and the
parties’ relative intent, knowledge, access to information and opportunity to correct or present such action or omission to act. The Company and Creation Capital agree that it would not be just and equitable if contributions were determined by
pro rata allocation or by any other method of allocation which does not take account of the equitable contributions referred to above. 
  
 Promptly after receipt by any Company Indemnified Person of notice of any pending or threatened litigation, such Company Indemnified Person will promptly
notify Creation Capital in writing of such matter; provided, however, that the failure to provide such prompt notice to Creation Capital shall not relieve Creation Capital of any liability which it may have to the Company Indemnified Person
unless such failure to provide such prompt notice to Creation Capital has materially prejudiced the defense of the litigation. In the event any such action is brought against any Company Indemnified Person, Creation Capital shall be entitled to
participate therein and to assume the defense thereof, with counsel reasonably satisfactory to the Company Indemnified Person, unless, however, the Company Indemnified Person reasonably determines that defenses may be available to the Company
Indemnified Person that are not available to Creation Capital and/or may not be consistent with the best interest of Creation Capital. In such event, the Company Indemnified Person shall have the right to assume its own defense, with counsel
reasonably satisfactory to Creation Capital, and shall so signify by promptly notifying Creation Capital in writing of its decision. Such decision shall not relieve Creation Capital of any liability which it may have to the Company Indemnified
Person, including the reimbursement of reasonable legal fees or other expenses incurred in connection with the Company Indemnified Person’s defense. Creation Capital shall not, without the prior written consent of the Company Indemnified
Person, effect any settlement of, consent to the entry of any judgment in, or otherwise seek to terminate any pending or threatened proceeding 

  

 12 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 
arising out of or relating to the engagement, unless such settlement includes an express, unconditional release of such Company Indemnified Person from all
liabilities asserted, or potential claims, against the Company Indemnified Person. Creation Capital shall not be liable for any settlement the Company Indemnified Person enters into without Creation Capital’s consent, which consent shall not be
unreasonably withheld. 
  
 General. 
  
 The obligations of the Company and Creation Capital referred to above shall
be in addition to any rights that any Creation Capital Indemnified Person or Company Indemnified Person may otherwise have at common law or otherwise, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal
representatives of any Creation Capital Indemnified Person, Company Indemnified Person, Creation Capital and the Company. 
  

 13 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. 

 EXECUTION COPY 
  
 EXHIBIT B 
  
  
 Potential Investors with Which the Company Has Had Prior Contacts

  

	1]	 	[*******] 

  

	2]	 	[*******] 

  

	3]	 	[*******] 

  

	4]	 	[*******] 

  

	5]	 	[*******] and 

  

	6)	 	[*******] 

  

 14 
  

 Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission
pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]